Digital Cognitive Behavioral Therapy Reduced Symptoms of Insomnia in Norwegian Adults
This study investigated the effect of a fully automated dCBT program on insomnia severity, sleep–wake patterns, sleep medication use, and daytime impairment.
Insomnia
Nighttime Device Use Associated With Insomnia in Young Adults
In young adults, the use of electronic devices was found to contribute to insomnia symptoms more than mood disturbance, age, and biological sex.
Comorbid ADHD, Insomnia Associated With Poorer Mental Functioning, Productivity
The combined burden of ADHD and insomnia may play a unique role in mental functioning and productivity, even after adjustment for other psychiatric comorbidities.
Study Looks at Phthalates, Sleep Quality in Women at Midlife
For midlife women, phthalate exposure seems to be associated with sleep disruption, with the associations observed in nonsmokers or former smokers.
Insomnia and Alcohol Consumption Linked to ADHD Symptoms
Among adults without a clinical diagnosis of ADHD, heavy alcohol use predicted more severe ADHD symptoms.
Lemborexant Now Available for Insomnia in Adult Patients
Lemborexant is now available for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adult patients.
Digital CBT Improves Insomnia, Anxiety, and Depression in Pregnant Women
Digital CBT involved 6 weekly remote sessions via website or iOS app lasting approximately 20 minutes and comprised sleep restriction, stimulus control, relaxation techniques, cognitive therapy, and sleep hygiene and education.
Schizophrenia and Bipolar Disorder May Share Sleep-Circadian Rhythm Phenotypes
Patients with bipolar disorder experienced significant reductions in sleep efficiency, which was not the case in patients with schizophrenia, although effect sizes for bipolar disorder were smaller overall.
Daridorexant Improves Sleep, Daytime Performance in Phase 3 Insomnia Study
Idorsia announced positive topline results from a phase 3 study of daridorexant, an investigational dual orexin receptor antagonist, for the treatment of insomnia.
Impaired Cognition in Children With OSA and Congenital Heart Disease
Children with congenital heart disease and comorbid obstructive sleep apnea are at increased risk for impaired neurocognition compared with children with congenital heart disease who do not have comorbid OSA.
-
Loading...
-
Loading...
Next post in Pediatric Neurology
